Search
for
Sort by
Research 301–330 of 1000+
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- New Drugs: Dutasteride
- Expression of an Olfactomedin-Related Gene in Rat Hair Follicular Papilla Cells
- Prefrontal 5α-reductase 2 mediates male-specific acute stress response
- Chapter 23. Therapeutic Control of Androgen Action
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Undariopsis peterseniana Promotes Hair Growth by the Activation of Wnt/β-Catenin and ERK Pathways
- Discontinuation of Alpha-Blockade after Initial Treatment with Finasteride and Doxazosin for Bladder Outlet Obstruction
- Patched-assoziierte Tumoren: Modifikatorgene und Pathogenese
- Drug Discovery Today: Therapeutic Strategies - 2006 Editorial
- Comparative study of the chemical profile, cytotoxic activity, and molecular docking of Serenoa repens extract and a pharmaceutical product
- LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Aesthetic dermatology procedures in coronavirus days
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- 1262 ONE YEAR FINASTERIDE THERAPY IN MEN WITH A SERUM PSA GREATER THAN 4 NG/ML WHO HAD UNDERGONE REPEAT BIOPSY
- Level-1 Data From the REDUCE Study and the PCPT Data